Search

everythinglearnresearchcommunity

for

Search:↓

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Two microRNAs in stem cell exosomes help treat hair loss by targeting a specific signaling pathway.

MPZL3 protein helps control the size of oil glands and the growth of oil-producing cells in both mice and humans.

The combination treatment showed a higher response rate but no significant survival benefits.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Cancer treatments targeting specific cells often cause skin problems, which can affect how much medicine patients can take.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Removing the liver tumor improved the patient's skin condition and hair growth.

Systemic therapy may reduce male infertility in psoriasis patients.

Hispanic patients in the USA have lower survival rates for melanoma compared to non-Hispanic Whites.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Controlling Tslp can improve health in AEC syndrome patients.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Lower SMAD2/3 activation predicts more severe skin cancer.